Document Detail

Medical devices; neurological devices; classification of repetitive transcranial magnetic stimulation system. Final rule.
MedLine Citation:
PMID:  21796846     Owner:  HSR     Status:  In-Process    
The Food and Drug Administration (FDA) is classifying the repetitive transcranial magnetic stimulation (rTMS) system into class II (special controls). The Agency is classifying this device type into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of these devices.
Related Documents :
11343116 - Symbiotic fungal endophytes control insect host-parasite interaction webs.
15918356 - Future increase in harmful algal blooms in the north sea due to climate change.
18705386 - Individual- and population-level responses of a keystone predator to geographic variati...
11752396 - Golden eagles, feral pigs, and insular carnivores: how exotic species turn native preda...
10447986 - Pleasure, pursuit of health or negotiation of identity? personality correlates of food ...
6507956 - Diagnosis of food allergies and intolerances in the study of prophylaxis and control gr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Federal register     Volume:  76     ISSN:  0097-6326     ISO Abbreviation:  Fed Regist     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-07-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7808722     Medline TA:  Fed Regist     Country:  United States    
Other Details:
Languages:  eng     Pagination:  44489-91     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmati...
Next Document:  The U.S. health system in perspective: a comparison of twelve industrialized nations.